[{"indications": "Indications\u00a0in combination with aspirin for the prevention of atherothrombotic\r\nevents in patients with acute coronary syndrome", "name": "TICAGRELOR", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "2 Cardiovascular system", "2.9 Antiplatelet drugs", "TICAGRELOR"], "cautions": "Cautions\u00a0patients at increased risk of bleeding\r\n(e.g. from recent trauma, surgery, gastro-intestinal bleeding, or\r\ncoagulation disorders); concomitant use\r\nof drugs that increase risk of bleeding; discontinue 7 days before elective surgery if antiplatelet effect\r\nnot desirable; bradycardia, sick sinus syndrome, or second- or third-degree AV block (unless pacemaker fitted); asthma  or chronic obstructive pulmonary\r\ndisease; history of hyperuricaemia; monitor renal function 1 month after initiation", "side-effects": "Side-effects\u00a0dyspnoea, haemorrhage, bruising; less\r\ncommonly nausea, vomiting, diarrhoea, abdominal pain, dyspepsia,\r\ngastritis, dizziness, headache, rash, pruritus; rarely constipation, paraesthesia, confusion, hyperuricaemia, raised serum\r\ncreatinine, vertigo", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/215689.htm", "doses": ["adult over 18 years, (with\r\naspirin\u2014see notes above) initially 180\u00a0mg as a single dose,\r\nthen 90\u00a0mg twice daily"], "pregnancy": "Pregnancy\u00a0manufacturer advises avoid\u2014toxicity in animal studies"}]